APA (7th ed.) Citation

BM, M., D, C., B, D., ZWM, L., JD, R., S, S., . . . AD, K. (2026). Safety, Utility, and Outcomes of Procainamide Challenge for the Diagnosis and Exclusion of Brugada Syndrome. Circulation, 153(3), 154. https://doi.org/10.1161/CIRCULATIONAHA.125.076011

Chicago Style (17th ed.) Citation

BM, Moore, et al. "Safety, Utility, and Outcomes of Procainamide Challenge for the Diagnosis and Exclusion of Brugada Syndrome." Circulation 153, no. 3 (2026): 154. https://doi.org/10.1161/CIRCULATIONAHA.125.076011.

MLA (9th ed.) Citation

BM, Moore, et al. "Safety, Utility, and Outcomes of Procainamide Challenge for the Diagnosis and Exclusion of Brugada Syndrome." Circulation, vol. 153, no. 3, 2026, p. 154, https://doi.org/10.1161/CIRCULATIONAHA.125.076011.